Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16176 - 16200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Carmustine	Approved Investigational	RCN1	5954	downregulated	Carmustine results in decreased expression of RCN1 mRNA	11p13	A21555
Carmustine	Approved Investigational	RGR	5995	downregulated	Carmustine results in decreased expression of RGR mRNA	10q23.1	A21555
Carmustine	Approved Investigational	RIT2	6014	downregulated	Carmustine results in decreased expression of RIT2 mRNA	18q12.3	A21555
Carmustine	Approved Investigational	RNASE4	6038	upregulated	Carmustine results in increased expression of RNASE4 mRNA	14q11.2	A21555
Carmustine	Approved Investigational	SEPT5	5413	downregulated	Carmustine results in decreased expression of SEPT5 mRNA	22q11.21	A21555
Carmustine	Approved Investigational	SFPQ	6421	downregulated	Carmustine results in decreased expression of SFPQ mRNA	1p34.3	A21555
Carmustine	Approved Investigational	SGCA	6442	downregulated	Carmustine results in decreased expression of SGCA mRNA	17q21.33	A21555
Carmustine	Approved Investigational	SHMT2	6472	downregulated	Carmustine results in decreased expression of SHMT2 mRNA	12q12-q14	A21555
Carmustine	Approved Investigational	SHOX	6473	downregulated	Carmustine results in decreased expression of SHOX mRNA	Xp22.33 and Yp11.32	A21555
Carmustine	Approved Investigational	SLC10A1	6554	upregulated	Carmustine results in increased expression of SLC10A1 mRNA	14q24.1	A21555
Carmustine	Approved Investigational	SLC16A2	6567	upregulated	Carmustine results in increased expression of SLC16A2 mRNA	Xq13.2	A21555
Carmustine	Approved Investigational	SLC30A3	7781	downregulated	Carmustine results in decreased expression of SLC30A3 mRNA	2p23.3	A21555
Carmustine	Approved Investigational	SLC6A2	6530	upregulated	Carmustine results in increased expression of SLC6A2 mRNA	16q12.2	A21555
Carmustine	Approved Investigational	SLCO1A2	6579	downregulated	Carmustine results in decreased expression of SLCO1A2 mRNA	12p12.1	A21555
Carmustine	Approved Investigational	SMARCD1	6602	upregulated	Carmustine results in increased expression of SMARCD1 mRNA	12q13.12	A21555
Carmustine	Approved Investigational	SMPD2	6610	upregulated	Carmustine results in increased expression of SMPD2 mRNA	6q21	A21555
Carmustine	Approved Investigational	SNAPC1	6617	upregulated	Carmustine results in increased expression of SNAPC1 mRNA	14q23.2	A21555
Carmustine	Approved Investigational	SNAPC3	6619	upregulated	Carmustine results in increased expression of SNAPC3 mRNA	9p22.3	A21555
Carmustine	Approved Investigational	SNCG	6623	upregulated	Carmustine results in increased expression of SNCG mRNA	10q23.2	A21555
Carmustine	Approved Investigational	SNRPB2	6629	upregulated	Carmustine results in increased expression of SNRPB2 mRNA	20p12.1	A21555
Carmustine	Approved Investigational	SOCS1	8651	downregulated	Carmustine results in decreased expression of SOCS1 mRNA	16p13.13	A20666
Carmustine	Approved Investigational	SORBS2	8470	downregulated	Carmustine results in decreased expression of SORBS2 mRNA	4q35.1	A21555
Carmustine	Approved Investigational	SPEG	10290	downregulated	Carmustine results in decreased expression of SPEG mRNA	2q35	A21555
Carmustine	Approved Investigational	SPRR2B	6701	downregulated	Carmustine results in decreased expression of SPRR2B mRNA	1q21.3	A21555
Carmustine	Approved Investigational	SRP14	6727	downregulated	Carmustine results in decreased expression of SRP14 mRNA	15q22	A21555

Displaying entries 16176 - 16200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability